HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey

Highlights COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment. Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of medical virology Vol. 92; no. 11; pp. 2288 - 2290
Main Authors:	Altuntas Aydin, Ozlem, Kumbasar Karaosmanoglu, Hayat, Kart Yasar, Kadriye
Format:	Journal Article
Language:	English
Published:	United States Wiley Subscription Services, Inc 01-11-2020
Subjects:	Adult Antibodies Antiretroviral therapy CD4 antigen CD4 Lymphocyte Count Coinfection - epidemiology Coinfection - virology Comorbidity COVID-19 COVID-19 - diagnostic imaging COVID-19 - epidemiology HIV HIV Infections - drug therapy HIV Infections - epidemiology Human immunodeficiency virus Humans Male Public health Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Tomography, X-Ray Computed Turkey - epidemiology Virology Turkey
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Highlights COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment. Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor in mortality in HIV/SARS‐CoV‐2 coinfected cases. Radiological imaging findings were observed in all HIV‐infected cases, even in the case with very low CD4 cell count. And, with immunochromatographic antibody tests, it was observed that antibody formation time was similar to uninfected individuals.
ISSN:	0146-6615 1096-9071
DOI:	10.1002/jmv.25955